Week Ending June 6, 2022

Challenges of Treating an Acute Hepatitis C Virus Infection With Concurrent Seizure Treatment in a Free Clinic
“Currently, there is limited data evaluating the coadministration of first-generation anticonvulsants for epilepsy treatment and direct-acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV) infection. There is a potential risk of suboptimal DAA serum concentrations that could potentially lead to HCV treatment failure.”

Liver Cancer Risk Doesn’t End With Successful Hepatitis C Treatment
“People with cirrhosis but no existing liver nodules may be at risk for developing hepatocellular carcinoma (HCC), the most common type of liver cancer, even after being cured of hepatitis C, according to study results published in the Journal of Hepatology.”

Strawberries May Be to Blame for Hepatitis A Outbreak
“The Food and Drug Administration is investigating a potential link between a hepatitis A outbreak and fresh organic strawberries. The contaminated strawberries were sold between March 5 and April 2 and branded as FreshKampo and HEB, according to the FDA, in collaboration with the Centers for Disease Control and Prevention (CDC), the Public Health Agency of Canada, the Canadian Food Inspection Agency and state and local partners.”

Barriers to uptake of hepatitis C medication
“La Trobe University researchers have found that multiple barriers continue to prevent some people from accessing life-saving new hepatitis C treatment, including experiences of stigma within the health care system.”

Types of Liver Disease and How to Treat Them
“Liver disease is a broad term that describes health conditions that damage the liver. As the body’s largest internal organ, the liver helps with vital functions like digesting food, processing substances, and filtering waste. When a person develops liver disease, the organ becomes damaged and can’t work properly.”

3rd Generation Hepatitis Vaccine Granted UK Authorization
“Massachusetts-based VBI Vaccines Inc. announced today that the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) had granted marketing authorization for PreHevbri™ for active immunization against infection caused by all known subtypes of hepatitis B virus (HBV) in adults.”

Improving and expanding self-testing for health equity
“The availability of self-tests for detecting diseases like COVID-19, HIV, and hepatitis C is changing the nature of individual and health provider relationships. These tests enable individuals to take charge of managing their own health and can reduce barriers to accessing diagnostics.”

Preoperative Antiviral Treatment for Hepatitis C Virus Improves Total Joint Arthroplasty Outcomes
“Preoperative antiviral treatment for hepatitis C virus (HCV) infection was associated with a decreased risk for periprosthetic joint infection (PJI) and other surgical-related complications in patients who underwent total joint arthroplasty (TJA), according to results of a study published in the Journal of Arthroplasty.”